Brain mitochondrial injury in human immunodeficiency virus-seropositive (HIV+) individuals taking nucleoside reverse transcriptase inhibitors

Journal of NeuroVirology

Volumn 11, Issue 4, 2005, Pages 356-364

  Schweinsburg, Brian C ^a,b,c,d,e   Taylor, Michael J ^a,b,e   Alhassoon, Omar M ^a,b,c,e   Gonzalez, Raul ^b,c,d,e   Brown, Gregory G ^a,b,e   Ellis, Ronald J ^b,e   Letendre, Scott ^b,e   Videen, John S ^b   McCutchan, J Allen ^b,e   Patterson, Thomas L ^a,b,e   Grant, Igor ^a,b,e  

^a VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c SAN DIEGO STATE UNIVERSITY   (United States)

^d SDSU/UCSD Joint Doctoral Program in Clinical Psycholog   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Brain magnetic resonance spectroscopy (MRS); Human immunodeficiency virus (HIV); Mitochondrial toxicity; N acetylaspartate; Nucleoside reverse transcriptase inhibitor (NRTI)

Indexed keywords

ABACAVIR; DIDANOSINE; EFAVIRENZ; INDINAVIR; LAMIVUDINE; N ACETYLASPARTIC ACID; NELFINAVIR; NEVIRAPINE; RITONAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; SAQUINAVIR; STAVUDINE; ZIDOVUDINE; ASPARTIC ACID; DRUG DERIVATIVE; N-ACETYLASPARTATE;

ADULT; ARTICLE; BRAIN MITOCHONDRION; CLINICAL ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; DISEASE DURATION; DISEASE SEVERITY; ENERGY METABOLISM; FEMALE; FRONTAL LOBE; GRAY MATTER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MITOCHONDRIAL ENCEPHALOPATHY; MITOCHONDRIAL RESPIRATION; MITOCHONDRIAL TOXICITY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; WHITE MATTER; BRAIN; CELL RESPIRATION; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DRUG EFFECT; METABOLISM; MIDDLE AGED; MITOCHONDRION; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATHOLOGY; TREATMENT OUTCOME;

HUMAN IMMUNODEFICIENCY VIRUS;

ADULT; ASPARTIC ACID; BRAIN; CELL RESPIRATION; DIDANOSINE; FEMALE; HIV INFECTIONS; HUMANS; LAMIVUDINE; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; MITOCHONDRIA; MITOCHONDRIAL DISEASES; REVERSE TRANSCRIPTASE INHIBITORS; STAVUDINE; TREATMENT OUTCOME; ZIDOVUDINE;

EID: 27144558377     PISSN: 13550284     EISSN: None     Source Type: Journal    
DOI: 10.1080/13550280591002342     Document Type: Article

References (39)

1. Barker PB, Lee RR, McArthur JC (1995). AIDS dementia complex: evaluation with proton MR spectroscopic imaging. Radiology 195: 58-64.
2. Bates TE, Strangward M, Keelan J, Davey GP, Munro PM, Clark JB (1996). Inhibition of N-acetylaspartate production: implications for 1H MRS studies in vivo. Neuroreport 7: 1397-1400.
3. Benbrik E, Chariot P, Bonavaud S, Ammi-Said M, Frisdal E, Rey C, et al (1997). Cellular and mitochondrial toxicity of zidovudine (AZT), didanosine (ddI) and zalcitabine (ddC) on cultured human muscle cells. J Neurol Sci 149: 19-25.
4. Bjartmar C, Battistuta J, Terada N, Dupree E, Trapp BD (2002). N-acetylaspartate is an axon-specific marker of mature white matter in vivo: a biochemical and immunohistochemical study on the rat optic nerve. Ann Neurol 51: 51-58.
5. Chang L, Miller BL, McBride D, Cornford M, Oropilla G, Buchthal S, et al (1995). Brain lesions in patients with AIDS: H-1 MR spectroscopy. Radiology 197: 525-531.
6. Chang L, Ernst T, Leonido-Yee M, Witt M, Speck O, Walot I, et al (1999). Highly active antiretroviral therapy reverses brain metabolite abnormalities in mild HIV dementia. Neurology 53: 782-789.
7. Demougeot C, Garnier P, Mossiat C, Bertrand N, Giroud M, Beley A, et al (2001). N-acetylaspartate, a marker of both cellular dysfunction and neuronal loss: its relevance to studies of acute brain injury. J Neurochem 77: 408-415.
8. Furman PA, Fyfe JA, St Clair MH, Weinhold K, Rideout JL, Freeman GA, et al (1986). Phosphorylation of 3′-azido-3′-deoxythymidine and selective interaction of the 5′-triphosphate with human immunodeficiency virus reverse transcriptase. Proc Natl Acad Sci U S A 83: 8333-8337.
9. Glynn SL, Yazdanian M (1998). In vitro blood-brain barrier permeability of nevirapine compared to other HIV antiretroviral agents. J Pharm Sci 87: 306-310.
10. Haas RH (2000). A comparison of genetic mitochondrial disease and nucleoside analogue toxicity. Does fetal nucleoside toxicity underlie reports of mitochondrial disease in infants born to women treated for HIV infection? Ann N Y Acad Sci 918: 247-261.
11. Iranzo A, Moreno A, Pujol J, Marti-Fabregas J, Domingo P, Molet J, et al (1999). Proton magnetic resonance spectroscopy pattern of progressive multifocal leukoencephalopathy in AIDS. J Neurol Neurosurg Psychiatry 66: 520-523.
12. Kakuda TN (2000). Pharmacology of nucleoside and nucleotide reverse transcriptase inhibitor-induced mitochondrial toxicity. Clin Ther 22: 685-708.
13. Laubenberger J, Haussinger D, Bayer S, Thielemann S, Schneider B, Mundinger A, et al (1996). HIV-related metabolic abnormalities in the brain: depiction with proton MR spectroscopy with short echo times. Radiology 199: 805-810.
14. Lim SE, Copeland WC (2001). Differential incorporation and removal of antiviral deoxynucleotides by human DNA polymerase gamma. J Biol Chem 276: 23616-23623.
15. Lopez-Villegas D, Lenkinski RE, Frank I (1997). Biochemical changes in the frontal lobe of HIV-infected individuals detected by magnetic resonance spectroscopy. Proc Natl Acad Sci U S A 94: 9854-9859.
16. Martin JL, Brown CE, Matthews-Davis N, Reardon JE (1994). Effects of antiviral nucleoside analogs on human DNA polymerases and mitochondrial DNA synthesis. Antimicrob Agents Chemother 38: 2743-2749.
17. McLean MA, Woermann FG, Barker GJ, Duncan JS (2000). Quantitative analysis of short echo time (1)H-MRSI of cerebral gray and white matter. Magn Reson Med 44: 401-411.
18. Menon DK, Ainsworth JG, Cox IJ, Coker RC, Sargentoni J, Coutts GA, et al (1992). Proton MR spectroscopy of the brain in AIDS dementia complex. J Comput Assist Tomogr 16: 538-542.
19. 1H magnetic resonance spectroscopic imaging. Neurology 43: 509-515.
20. 1H MRSI in cognitively impaired HIV-seropositive individuals. Magn Reson Imaging 12: 653-659.
21. Moffett JR, Namboodiri MA, Cangro CB, Neale JH (1991). Immunohistochemical localization of N-acetylaspartate in rat brain. Neuroreport 2: 131-134.
22. Möller HE, Vermathen P, Lentschig MG, Schuierer G, Schwarz S, Wiedermann D, et al (1999). Metabolic characterization of AIDS dementia complex by spectroscopic imaging. J Magn Reson Imaging 9: 10-18.
23. Naviaux RK, Markusic D, Barshop BA, Nyhan WL, Haas RH (1999). Sensitive assay for mitochondrial DNA polymerase gamma. Clin Chem 45: 1725-1733.
24. Paley M, Cozzone PJ, Alonso J, Vion-Dury J, Confort-Gouny S, Wilkinson ID, et al (1996). A multicenter proton magnetic resonance spectroscopy study of neurological complications of AIDS. AIDS Res Hum Retroviruses 12: 213-222.
25. Paley M, Wilkinson ID, Hall-Craggs MA, Chong WK, Chinn RJ, Harrison MJ (1995). Short echo time proton spectroscopy of the brain in HIV infection/AIDS. Magn Reson Imaging 13: 871-875.
26. Pan-Zhou XR, Cui L, Zhou XJ, Sommadossi JP, Darley-Usmar VM (2000). Differential effects of antiretroviral nucleoside analogs on mitochondrial function in HepG2 cells. Antimicrob Agents Chemother 44: 496-503.
27. Provencher SW (1993). Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 30: 672-679.
28. Salvan AM, Vion-Dury J, Confort-Gouny S, Nicoli F, Lamoureux S, Cozzone PJ (1997a). Brain proton magnetic resonance spectroscopy in HIV-related encephalopathy: identification of evolving metabolic patterns in relation to dementia and therapy. AIDS Res Hum Retroviruses 13: 1055-1066.
29. Salvan AM, Vion-Dury J, Confort-Gouny S, Nicoli F, Lamoureux S, Cozzone PJ (1997b). Cerebral metabolic alterations in human immunodeficiency virus-related encephalopathy detected by proton magnetic resonance spectroscopy. Comparison between sequences using short and long echo times. Invest Radiol 32: 485-495.
30. 1H magnetic resonance spectroscopy investigation of alcohol-associated frontal lobe injury. Alcohol Clin Exp Res 25: 924-934.
31. Schweinsburg BC, Taylor MJ, Videen JS, Alhassoon OM, Patterson TL, Grant I (2000). Elevated myo-inositol in gray matter of recently detoxified but not long-term abstinent alcoholics: a preliminary MR spectroscopy study. Alcohol Clin Exp Res 24: 699-705.
32. Signoretti S, Marmarou A, Tavazzi B, Lazzarino G, Beaumont A, Vagnozzi R (2001). N-acetylaspartate reduction as a measure of injury severity and mitochondrial dysfunction following diffuse traumatic brain injury. J Neurotrauma 18: 977-991.
33. Simmons ML, Frondoza CG, Coyle JT (1991). Immunocytochemical localization of N-acetyl aspartate with monoclonal antibodies. Neuroscience 45: 37-45.
34. 1H-MR spectroscopy for metabolic characterisation of diffuse and focal brain lesions in patients infected with HIV. J Neurol Neurosurg Psychiatry 64: 516-523.
35. Tracey I, Carr CA, Guimaraes AR, Worth JL, Navia BA, Gonzalez RG (1996). Brain choline-containing compounds are elevated in HIV-positive patients before the onset of AIDS dementia complex: a proton magnetic resonance spectroscopic study. Neurology 46: 783-788.
36. Vion-Dury J, Nicoli F, Salvan AM, Confort-Gouny S, Dhiver C, Cozzone PJ (1995). Reversal of brain metabolic alterations with zidovudine detected by proton localised magnetic resonance spectroscopy. Lancet 345: 60-61.
37. Wilkinson ID, Miller RF, Miszkiel KA, Paley MN, Hall-Craggs MA, Baldeweg T, et al (1997). Cerebral proton magnetic resonance spectroscopy in asymptomatic HIV infection. AIDS 11: 289-295.
38. Wilkinson ID, Miller RF, Paley MN, Miszkiel KA, Kendall BE, Hall-Craggs MA, et al (1996). Cerebral proton magnetic resonance spectroscopy in cytomegalovirus encephalitis and HIV leucoencephalopathy/encephalitis. AIDS 10: 1443-1444.
39. Youssef JA, Badr MZ (1992). Disruption of mitochondrial energetics and DNA synthesis by the anti-AIDS drug dideoxyinosine. Toxicol Lett 60: 197-202.